dactinomycin has been researched along with Intestinal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arda-Pirincci, P; Bolkent, S | 1 |
| Moore, FD; Stuart, FP; Torres, E | 1 |
2 other study(ies) available for dactinomycin and Intestinal Diseases
| Article | Year |
|---|---|
The role of glucagon-like peptide-2 on apoptosis, cell proliferation, and oxidant-antioxidant system at a mouse model of intestinal injury induced by tumor necrosis factor-alpha/actinomycin D.
Topics: Animals; Antioxidants; Apoptosis; Cell Proliferation; Dactinomycin; Disease Models, Animal; Drug Evaluation, Preclinical; Gastrointestinal Agents; Glucagon-Like Peptide 2; Intestinal Diseases; Male; Mice; Mice, Inbred BALB C; Oxidants; Tumor Necrosis Factor-alpha | 2011 |
The association of upper gastrointestinal ulceration and orthotopic hepatic allotransplantation in the dog.
Topics: Animals; Azathioprine; Biliary Tract Surgical Procedures; Cholecystectomy; Dactinomycin; Dogs; Gastrectomy; Gastroenterostomy; Immunosuppressive Agents; Intestinal Diseases; Liver; Liver Transplantation; Peptic Ulcer; Peptic Ulcer Hemorrhage; Transplantation Immunology; Transplantation, Homologous; Ulcer | 1967 |